25Feb 2025
Adverse Prognostic Pathways in Metastatic Castration-Resistant Prostate Cancer

Adverse Prognostic Pathways in Metastatic Castration-Resistant Prostate Cancer

The study analyzed 1012 metastatic castration-resistant prostate cancer (mCRPC) tissue samples to identify gene expression-based pathways associated with clinical outcomes. Five key pathway clusters were found, with loss of AR signaling, high proliferation, and glycolysis/mTOR signaling being adverse prognostic factors. AR signaling inhibitors did not permanently target these pathways, suggesting the need for more effective treatments. The findings can guide clinical prognostication.

  • #oncology
  • #andrology

Like

Save

Share